These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8839289)

  • 1. Quantitation of multistage carcinogenesis in rat liver.
    Pitot HC; Dragan YP; Teeguarden J; Hsia S; Campbell H
    Toxicol Pathol; 1996; 24(1):119-28. PubMed ID: 8839289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical parameters in the quantitation of the stages of initiation, promotion, and progression in one model of hepatocarcinogenesis in the rat.
    Pitot HC; Campbell HA; Maronpot R; Bawa N; Rizvi TA; Xu YH; Sargent L; Dragan Y; Pyron M
    Toxicol Pathol; 1989; 17(4 Pt 1):594-611; discussion 611-2. PubMed ID: 2697939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The initiation-promotion-progression model of rat hepatocarcinogenesis.
    Dragan YP; Sargent L; Xu YD; Xu YH; Pitot HC
    Proc Soc Exp Biol Med; 1993 Jan; 202(1):16-24. PubMed ID: 8093813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incorporation of bromodeoxyuridine in glutathione S-transferase-positive hepatocytes during rat multistage hepatocarcinogenesis.
    Dragan YP; Hully J; Crow R; Mass M; Pitot HC
    Carcinogenesis; 1994 Sep; 15(9):1939-47. PubMed ID: 7923588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative stereological analysis of the effects of age and sex on multistage hepatocarcinogenesis in the rat by use of four cytochemical markers.
    Xu YH; Campbell HA; Sattler GL; Hendrich S; Maronpot R; Sato K; Pitot HC
    Cancer Res; 1990 Feb; 50(3):472-9. PubMed ID: 1967547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Karyotypic changes in a multistage model of chemical hepatocarcinogenesis in the rat.
    Sargent L; Dragan Y; Xu YH; Sattler G; Wiley J; Pitot HC
    Cancer Res; 1996 Jul; 56(13):2985-91. PubMed ID: 8674052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of hepatocyte phenotypes at the glutathione transferase and albumin loci in Sprague-Dawley and Nagase analbuminemic rats and F1 progeny after initiation and promotion.
    Dragan YP; Peterson J; Pitot HC
    Carcinogenesis; 1993 Jul; 14(7):1313-9. PubMed ID: 8330343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the separate and combined administration of mestranol and phenobarbital on the development of altered hepatic foci expressing placental form of glutathione S-transferase in the rat.
    Dragan YP; Singh J; Pitot HC
    Carcinogenesis; 1996 Sep; 17(9):2043-52. PubMed ID: 8824533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Focal and non-focal hepatic expression of placental glutathione S-transferase in carcinogen-treated rats.
    Dragan YP; Campbell HA; Baker K; Vaughan J; Mass M; Pitot HC
    Carcinogenesis; 1994 Nov; 15(11):2587-91. PubMed ID: 7955110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effect of α-lipoic acid on thioacetamide-induced tumor promotion through suppression of inflammatory cell responses in a two-stage hepatocarcinogenesis model in rats.
    Fujii Y; Segawa R; Kimura M; Wang L; Ishii Y; Yamamoto R; Morita R; Mitsumori K; Shibutani M
    Chem Biol Interact; 2013 Sep; 205(2):108-18. PubMed ID: 23830814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A clonal growth model: time-course simulations of liver foci growth following penta- or hexachlorobenzene treatment in a medium-term bioassay.
    Ou YC; Conolly RB; Thomas RS; Xu Y; Andersen ME; Chubb LS; Pitot HC; Yang RS
    Cancer Res; 2001 Mar; 61(5):1879-89. PubMed ID: 11280742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The quantitation of altered hepatic foci during multistage hepatocarcinogenesis in the rat: transforming growth factor alpha expression as a marker for the stage of progression.
    Dragan Y; Teeguarden J; Campbell H; Hsia S; Pitot H
    Cancer Lett; 1995 Jun; 93(1):73-83. PubMed ID: 7600545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor-alpha in carcinogen-induced F344 rat hepatic foci.
    Steinmetz KL; Klaunig JE
    Toxicol Appl Pharmacol; 1996 Sep; 140(1):131-45. PubMed ID: 8806879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-parenchymal liver cells support the growth advantage in the first stages of hepatocarcinogenesis.
    Drucker C; Parzefall W; Teufelhofer O; Grusch M; Ellinger A; Schulte-Hermann R; Grasl-Kraupp B
    Carcinogenesis; 2006 Jan; 27(1):152-61. PubMed ID: 16081514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of experimental and theoretical parameters of the Moolgavkar-Venzon-Knudson incidence function for the stages of initiation and promotion in rat hepatocarcinogenesis.
    Dragan YP; Hully J; Baker K; Crow R; Mass MJ; Pitot HC
    Toxicology; 1995 Sep; 102(1-2):161-75. PubMed ID: 7482551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary supplementation of the citrus antioxidant auraptene inhibits N,N-diethylnitrosamine-induced rat hepatocarcinogenesis.
    Sakata K; Hara A; Hirose Y; Yamada Y; Kuno T; Katayama M; Yoshida K; Zheng Q; Murakami A; Ohigashi H; Ikemoto K; Koshimizu K; Tanaka T; Mori H
    Oncology; 2004; 66(3):244-52. PubMed ID: 15218316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A semipurified diet that suppresses phenobarbital promotion of hepatocarcinogenesis in the rat.
    Hendrich S; Glauert HP; Pitot HC
    Nutr Cancer; 1989; 12(3):249-58. PubMed ID: 2771802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disruption of Smad-dependent signaling for growth of GST-P-positive lesions from the early stage in a rat two-stage hepatocarcinogenesis model.
    Ichimura R; Mizukami S; Takahashi M; Taniai E; Kemmochi S; Mitsumori K; Shibutani M
    Toxicol Appl Pharmacol; 2010 Aug; 246(3):128-40. PubMed ID: 20423715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer initiating properties of fumonisin B1 in a short-term rat liver carcinogenesis assay.
    Gelderblom WC; Marasas WF; Lebepe-Mazur S; Swanevelder S; Abel S
    Toxicology; 2008 Sep; 250(2-3):89-95. PubMed ID: 18616970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical markers associated with the stages of promotion and progression during hepatocarcinogenesis in the rat.
    Pitot HC; Dragan Y; Sargent L; Xu YH
    Environ Health Perspect; 1991 Jun; 93():181-9. PubMed ID: 1723043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.